Individualised Predictions of the Survival Benefit Due to Adjuvant Therapy in a Randomised Trial of Sorafenib after Nephrectomy for Localised Renal Cell Carcinoma

BACKGROUND: Little has been published regarding how doctors think and talk about prognosis and the potential benefits of adjuvant therapy. OBJECTIVE: We sought predictions of survival rates and survival times, for patients with and without adjuvant therapy, from the clinicians of patients participat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Kidney cancer 2020-12, Vol.4 (4), p.185-195
Hauptverfasser:	Lawrence, Nicola J., Martin, Andrew, Davis, Ian D., Troon, Simon, Sengupta, Shomik, Hovey, Elizabeth, Coskinas, Xanthi, Kaplan, Richard, Smith, Benjamin, Ritchie, Alastair W. S., Meade, Angela, Goh, Jeffrey, Gurney, Howard, Harrison, Michelle, Fife, Kate, Eisen, Tim, Blinman, Prunella, Stockler, Martin R.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!